Wells Fargo & Company Zomedica Corp. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Zomedica Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 36,945 shares of ZOM stock, worth $5,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,945
Previous 37,057
0.3%
Holding current value
$5,541
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ZOM
# of Institutions
98Shares Held
84.2MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$7.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.1MShares$1.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.48 Million0.0% of portfolio
-
State Street Corp Boston, MA3.11MShares$466,5870.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$369,9790.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $147M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...